Georgia's Online Cancer Information Center

Find A Clinical Trial

A Phase 1 / 2 Multicenter Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Subjects With Relapsed / Refractory Chronic Lymphocytic Leukemia

Status
Active
Cancer Type
Leukemia
Lymphoma
Trial Phase
Phase I
Phase II
Eligibility
18 Years and older, Male and Female
Study Type
Treatment
NCD ID
NCT03624036
Protocol IDs
KTE-C19-108 (primary)
NCI-2018-02958
2018-001923-38
Study Sponsor
Kite, A Gilead Company

Summary

The primary objective of this study is to evaluate the safety (Phase 1) and efficacy (Phase 2) of KTE-C19 in adults with relapsed / refractory chronic lymphocytic leukemia (r / r CLL).
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.